Biofrontera (BFRI) to Release Earnings on Friday

Biofrontera (NASDAQ:BFRI) is projected to announce its earnings results before the market opens on Friday, March 21st. Analysts expect the company to announce earnings of $0.02 per share and revenue of $14.53 million for the quarter. Parties that are interested in participating in the company’s conference call can do so using this link.

Biofrontera Stock Up 1.3 %

Shares of BFRI stock opened at $1.00 on Thursday. The firm has a market cap of $7.75 million, a price-to-earnings ratio of -0.44 and a beta of 0.30. The stock has a 50-day moving average price of $1.05 and a 200 day moving average price of $1.03. Biofrontera has a 12 month low of $0.65 and a 12 month high of $2.43.

Biofrontera Company Profile

Biofrontera Inc, a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection.